British Journal of Clinical Pharmacology · 2005 · 88 citations · 18 references
Life SciencesGeneticsMolecular GeneticsGenetic EpidemiologyHuman GeneticsMedical GeneticsGenotype-phenotype Association AnalysisMolecular TypingCyp2c9 GenotypingCytochrome P450 Genetic PolymorphismCytochrome P450 GenotypingPopulation Frequency Analysis
AIMS: To determine the frequencies of the variant alleles and the genotypes of CYP2C9 in a Korean population. METHODS: Three hundred and fifty-eight healthy Korean subjects were studied. CYP2C9 alleles were detected by polymerase chain reaction-restriction fragment length polymorphism assays and direct sequencing assays. RESULTS: The allele frequencies were 0.934 for CYP2C9*1, 0.060 for CYP2C9*3 and 0.006 for CYP2C9*13. The CYP2C9*2,*4,*5 and *11 alleles were not detected. The frequencies of the CYP2C9*1/*1, *1/*3 and *1/*13 genotypes were 0.869, 0.120 and 0.011, respectively. CONCLUSION: The frequency of the CYP2C9*3 allele in the Korean population studied was significantly higher than reported elsewhere, and a novel allele, CYP2C9*13, was found at a frequency of 0.006 (95% confidence interval 0, 0.012). Only three genotypes of CYP2C9, CYP2C9*1/*1,*1/*3 and *1/*13 were observed in this Korean population.
18
The role of the CFP2C9-Leu 359 allelic variant in the tolbutamide polymorphism
Theresa H. Sullivan-Klose, Burhan I. Ghanayem, Douglas A. Bell et al. · Pharmacogenetics · 1996 · 587 citations
Medicine, Genetics, Pharmacology +17
Detection of CYP2C9 polymorphism based on the polymerase chain reaction in Chinese
Su-Lan Wang, Jin‐ding Huang, Ming‐Derg Lai et al. · Pharmacogenetics · 1995 · 195 citations